GSK's malaria vaccine to go to regulators in 2014
This article was originally published in Scrip
GlaxoSmithKline's pioneering malaria vaccine looks like it could arrive within two years. The company says it will file for approval of the RTS,S vaccine with the European Medicines Agency next year, based on the latest data from its large-scale Phase III trial. It added that the World Health Organization has indicated that a policy recommendation for the RTS,S malaria vaccine candidate is possible as early as 2015 if it is granted a positive scientific opinion by EMA, paving the way for decisions by African nations regarding large-scale implementation of the vaccine through their national immunization programs.